With an international reputation for clinical excellence and ongoing investment in the latest treatment technology, GFNH is at the forefront of modern medicine and surgery in Turkey having been founded in 1989 as the first hospital for cardiovascular diseases in the region under the aegis of the Turkish Cardiology Foundation.

Today there are 4 general hospitals, 2 medical centers, as well as Istanbul Bilim University which inhabits a medical faculty, a school of nursing and a vocational school of healthcare within the Group.

The Group has maintained its reputation for excellence by combining expertise with the highest caliber of staff and healthcare innovation to ensure that each and every patient receives the best care possible.

All facilities are JCI and ISO accredited. Additionally, Istanbul FNH was also awarded Sign of the City in 2014 and British QHA accreditation in 2015.

GROUP FLORENCE NIGHTINGALE IN FIGURES

• 700 patient bed capacity, 36 Operating Rooms, 122 ICU Beds
• 40.000 patients treated every year
• 41.000 Heart Surgeries (an average of 30-35 patients every week in 2010)
• The lowest mortality rate in cardiology in Europe – 1,53% in 2010 & annual General Infection Definition of 1,53%)
• 8 Vertebral & Scoliosis Surgeries per week
• 140.000 Angiographies & Angioplasties
• 8.000 Angiographies a year
• 7 Stem Cell Transplantation cases per month
• 20.000 Orthopedic Surgeries
• 300 Robotic Surgeries in Urology
• More than 1.000 Liver Transplantations
• 2.000 Invasive Cardiac interventions a year
• 2.000 Heart Surgeries a year

“FIRSTS”

• 1st Stent Operation in the region (1991)
• 1st Robotic Surgery Operation in the region (2004)
• 1st Liver Transplantation in the region as a private hospital (2004)
• 1st Stroke Center in the region as a private hospital (2005)
• 1st Comprehensive Cancer Center in the region (2007)
• 1st PET-MRI in Turkey and the region (2016)
• INTERNATIONAL COOPERATION and PARTNERSHIPS

Group Florence Nightingale collaborates with world-renowned hospitals and medical schools to offer its patients state-of-the-art diagnostics and treatment methods:

• Memorial Sloan-Kettering Cancer Center, New York
• Methodist Hospital, Houston
• Columbia University Medical Center, New York
• Weill Medical College of Cornell University, New York
• Barbara Ann Karmanos Cancer Institute, Detroit
• Baylor College of Medicine, Houston
• Center for Cell Therapy and Cancer Immunotherapy, Tel Aviv
• Detroit Medical Center, Detroit
• Wayne State University School of Medicine, Detroit